Greece vs Solomon Islands: The number of people with susceptibility test result for rifampicin
Greece
45.08
in 2021
Solomon Islands
45.52
in 2021
Greece rank
119th
Solomon Islands rank
118th
The number of people with susceptibility test result for rifampicin over time
- Greece
- Solomon Islands
How they compare
Solomon Islands currently reports 45.52 against 45.08 in Greece, a difference of 0.44.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Greece ahead.
Greece ranks 119th and Solomon Islands ranks 118th of 146 countries.
Greece has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Greece | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 55.64 | 0 | 55.64 | Greece |
| 2020s | 69.01 | 55.88 | 13.12 | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Greece or Solomon Islands?
- Solomon Islands, at 45.52 against 45.08 in Greece as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Greece and Solomon Islands?
- 0.44, with Solomon Islands ahead.
- How many years of comparable data are there for Greece and Solomon Islands?
- 5 years are reported by both, from 2017 to 2021.
- How do Greece and Solomon Islands rank globally for the number of people with susceptibility test result for rifampicin?
- Greece ranks 119th and Solomon Islands ranks 118th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.